[HTML][HTML] Междисциплинарные клинические рекомендации «Лечение ожирения и коморбидных заболеваний»

ИИ Дедов, МВ Шестакова… - Ожирение и …, 2021 - cyberleninka.ru
Клинические рекомендации уже давно вошли в число рабочих инструментов
современного врача, помогая ему быстро ориентироваться в наиболее эффективных …

Options for pharmacological management of obesity in patients treated with atypical antipsychotics

U Werneke, D Taylor, TAB Sanders - International Clinical …, 2002 - journals.lww.com
Obesity is associated with considerable morbidity and decreased life expectancy. Weight
gain is a commonly encountered problem associated with antipsychotic treatment. We …

A randomized trial of sibutramine in the management of obese type 2 diabetic patients treated with metformin

SJ McNulty, E Ur, G Williams… - Diabetes …, 2003 - Am Diabetes Assoc
OBJECTIVE—To evaluate the effects of sibutramine (15 and 20 mg/day) on weight,
metabolic control, and blood pressure in metformin-treated obese subjects with type 2 …

Documento de consenso: obesidad y riesgo cardiovascular

J Aranceta, M Foz, B Moreno, B Gil, E Jover… - Clínica e investigación …, 2003 - Elsevier
La Sociedad Española para el Estudio de la Obesidad (SEEDO) promovió la realización del
estudio SEEDO'97, basado en el análisis de un pool de datos conformado con indicadores …

Management of obesity in the elderly: special considerations

MH Horani, AD Mooradian - Treatments in endocrinology, 2002 - Springer
Over the last few decades, there has been an unprecedented increase in the prevalence of
obesity, especially in economically developed countries. Furthermore, it is becoming an …

Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients

A Kaya, N Aydın, P Topsever, M Filiz, A Öztürk… - Biomedicine & …, 2004 - Elsevier
Objectives.–To compare changes in anthropometric measures [body mass index (BMI), body
weight] of obese patients treated with diet and exercise alone or additionally sibutramine …

Sleep and rhythm consequences of a genetically induced loss of serotonin

S Leu-Semenescu, I Arnulf, C Decaix, F Moussa, F Clot… - Sleep, 2010 - academic.oup.com
Background: A genetic deficiency in sepiapterin reductase leads to a combined deficit of
serotonin and dopamine. The motor phenotype is characterized by a dopa-responsive …

Memantine reduces consumption of highly palatable food in a rat model of binge eating

P Popik, T Kos, Y Zhang, A Bisaga - Amino Acids, 2011 - Springer
Excessive consumption of highly palatable food has been linked to the development of
eating disorders and obesity, and can be modeled in non-food-deprived rats by offering …

Tratamiento médico de la obesidad mórbida: alternativas actuales, límites y perspectivas

AM Rubio, C Moreno - Cirugía Española, 2004 - Elsevier
El tratamiento de la obesidad descansa fundamentalmente en la modificación de los
factores ambientales (dieta, junto a una actividad física aeróbica regulary la modificación de …

Use of sibutramine in obese Hispanic adolescents

R Violante-Ortíz, BE Del-Rio-Navarro… - Advances in …, 2005 - Springer
A study on the treatment of obese adolescents with the use of sibutramine in private practice
is presented. Patients consisted of 24 boys and 43 girls with obesity (body mass index …